CVS vs RYN · P/E 16, rev $402.07B vs P/E 45, rev $1.26B
CVS Health Corp (CVS) versus Rayonier Inc (RYN) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Rayonier Inc (RYN) is a reit - specialty company listed on NYSE.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported RYN revenue for 2024-12-31 was $1.26B. Net income was $369.0M. Revenue was up 19.5% from 2023-12-31 to 2024-12-31. RYN currently screens at market cap $6.27B and trailing P/E 45.1.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. RYN currently screens at market cap $6.27B and trailing P/E 45.1.
Not investment advice. Open the CVS and RYN stock pages for the full models.
Not investment advice.